These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2179590)

  • 1. Mortality rates after 10.5 years for participants in the Multiple Risk Factor Intervention Trial. Findings related to a priori hypotheses of the trial. The Multiple Risk Factor Intervention Trial Research Group.
    JAMA; 1990 Apr; 263(13):1795-801. PubMed ID: 2179590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
    Circulation; 1990 Nov; 82(5):1616-28. PubMed ID: 2225366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.
    JAMA; 1982 Sep; 248(12):1465-77. PubMed ID: 7050440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1985 Jan; 55(1):16-24. PubMed ID: 2857061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1986 Jul; 58(1):1-13. PubMed ID: 2873741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.
    Circulation; 1996 Sep; 94(5):946-51. PubMed ID: 8790030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
    Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
    Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.
    Shaten BJ; Kuller LH; Kjelsberg MO; Stamler J; Ockene JK; Cutler JA; Cohen JD
    Ann Epidemiol; 1997 Feb; 7(2):125-36. PubMed ID: 9099400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The drug treatment of mild hypertension in the Multiple Risk Factor Intervention Trial. A review.
    Grimm RH
    Drugs; 1986; 31 Suppl 1():13-21. PubMed ID: 3720569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Am J Cardiol; 1985 Jan; 55(1):1-15. PubMed ID: 3880997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-stage screening and mortality in the Multiple Risk Factor Intervention Trial.
    Eberly LE; Neaton JD; Thomas AJ; Yu D;
    Clin Trials; 2004; 1(2):148-61. PubMed ID: 16281887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.
    Rautaharju PM; Neaton JD
    Clin Invest Med; 1987 Nov; 10(6):606-15. PubMed ID: 3326700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
    Grimm RH; Cohen JD; Smith WM; Falvo-Gerard L; Neaton JD
    Arch Intern Med; 1985 Jul; 145(7):1191-9. PubMed ID: 3893343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise-based rehabilitation for coronary heart disease.
    Jolliffe JA; Rees K; Taylor RS; Thompson D; Oldridge N; Ebrahim S
    Cochrane Database Syst Rev; 2000; (4):CD001800. PubMed ID: 11034729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brief description of the Multiple Risk Factor Intervention Trial.
    Kjelsberg MO; Cutler JA; Dolecek TA
    Am J Clin Nutr; 1997 Jan; 65(1 Suppl):191S-195S. PubMed ID: 8988937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heart rate adjustment of exercise-induced ST-segment depression identifies men who benefit from a risk factor reduction program.
    Okin PM; Prineas RJ; Grandits G; Rautaharju PM; Cohen JD; Crow RS; Kligfield P
    Circulation; 1997 Nov; 96(9):2899-904. PubMed ID: 9386155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial.
    Dolecek TA
    Proc Soc Exp Biol Med; 1992 Jun; 200(2):177-82. PubMed ID: 1579579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum cholesterol level and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
    Neaton JD; Blackburn H; Jacobs D; Kuller L; Lee DJ; Sherwin R; Shih J; Stamler J; Wentworth D
    Arch Intern Med; 1992 Jul; 152(7):1490-500. PubMed ID: 1627030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oslo Study Diet and Antismoking Trial. Results after 102 months.
    Hjermann I; Holme I; Leren P
    Am J Med; 1986 Feb; 80(2A):7-11. PubMed ID: 3511692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The Roman coronary heart disease prevention program. Final results].
    G Ital Cardiol; 1982; 12(8):541-54. PubMed ID: 7169153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.